Of the 1,308 cases with EGFR mutations found by NGS, 65.3% of the cases (854/1,308) harbored non-EGFR mutations in 18 tumor-related genes, with TP53 being the most frequently mutated (Figure 3B). Here, TP53 is linked to neoplasm.